BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35114404)

  • 1. Drug-induced antiphospholipid syndrome: Analysis of the WHO international database.
    Gérardin C; Bihan K; Salem JE; Khachatryan H; Gerotziafas G; Fain O; Mekinian A
    Autoimmun Rev; 2022 May; 21(5):103060. PubMed ID: 35114404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.
    Arnaud L; Mertz P; Gavand PE; Martin T; Chasset F; Tebacher-Alt M; Lambert A; Muller C; Sibilia J; Lebrun-Vignes B; Salem JE
    Ann Rheum Dis; 2019 Apr; 78(4):504-508. PubMed ID: 30793701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of auto-immune hepatitis associated with the use of anti-TNFα agents: An analysis of 389 cases in VigiBase.
    Vollmer O; Felten R; Mertz P; Lebrun-Vignes B; Salem JE; Arnaud L
    Autoimmun Rev; 2020 Mar; 19(3):102460. PubMed ID: 31917266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
    Salem JE; Nguyen LS; Moslehi JJ; Ederhy S; Lebrun-Vignes B; Roden DM; Funck-Brentano C; Gougis P
    Eur Heart J; 2021 Oct; 42(38):3915-3928. PubMed ID: 34370839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis.
    Adjaï F; Fournier D; Dolladille C; Lebrun-Vignes B; Bihan K
    Therapie; 2024 Mar; ():. PubMed ID: 38584049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database.
    Konstantinov K; Dolladille C; Gillet B; Alexandre J; Aouba A; Deshayes S; Repesse Y
    Haemophilia; 2023 Jan; 29(1):186-192. PubMed ID: 36367755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced delusion: A comprehensive overview of the WHO pharmacovigilance database.
    Balcerac A; Baldacci A; Romier A; Annette S; Lemarchand B; Bihan K; Bottemanne H
    Psychiatry Res; 2023 Sep; 327():115365. PubMed ID: 37517106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sipuleucel-T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database.
    Moey MYY; Jiwani RA; Takeda K; Prenshaw K; Kreeger RW; Inzerillo J; Liles DK; Marcu CB; Lebrun-Vignes B; Morris DL; Ardhanari S; Salem JE
    ESC Heart Fail; 2021 Aug; 8(4):3360-3368. PubMed ID: 33938158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database.
    Dumont A; Dolladille C; de Boysson H; Alexandre J; Nguyen A; Deshayes S; Aouba A
    Autoimmun Rev; 2022 Sep; 21(9):103157. PubMed ID: 35902047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysis.
    Bataille P; Lebrun-Vignes B; Bettuzzi T; Ingen-Housz-Oro S; Hadj-Rabia S; Welfringer-Morin A; Bodemer C
    J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38682703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs associated with posterior reversible encephalopathy syndrome, a worldwide signal detection study.
    Balcerac A; Bihan K; Psimaras D; Lebrun-Vignes B; Salem JE; Weiss N
    J Neurol; 2023 Feb; 270(2):975-985. PubMed ID: 36329183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database.
    Li J; Zelmat Y; Storck W; Laforgue EJ; Yrondi A; Balcerac A; Sommet A; Montastruc F
    J Affect Disord; 2024 Apr; 350():452-467. PubMed ID: 38244800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database.
    Anquetil C; Salem JE; Lebrun-Vignes B; Touhami S; Desbois AC; Maalouf G; Domont F; Allenbach Y; Cacoub P; Bodaghi B; Saadoun D
    J Autoimmun; 2020 Jul; 111():102454. PubMed ID: 32303423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Worldwide Pharmacoepidemiologic Update on Drug-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Era of Targeted Therapies.
    Deshayes S; Dolladille C; Dumont A; Martin Silva N; Chretien B; De Boysson H; Alexandre J; Aouba A
    Arthritis Rheumatol; 2022 Jan; 74(1):134-139. PubMed ID: 34164938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
    Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
    Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities.
    Allenbach Y; Anquetil C; Manouchehri A; Benveniste O; Lambotte O; Lebrun-Vignes B; Spano JP; Ederhy S; Klatzmann D; Rosenzwajg M; Fautrel B; Cadranel J; Johnson DB; Moslehi JJ; Salem JE
    Autoimmun Rev; 2020 Aug; 19(8):102586. PubMed ID: 32535094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database.
    Cohen Aubart F; Lhote R; Amoura A; Valeyre D; Haroche J; Amoura Z; Lebrun-Vignes B
    J Intern Med; 2020 Sep; 288(3):356-362. PubMed ID: 31612562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database.
    Balcerac A; Bihan K; Lebrun-Vignes B; Thabut D; Salem JE; Weiss N
    Ann Intensive Care; 2022 Jun; 12(1):55. PubMed ID: 35716335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.